Illumina, Inc. vs Payoneer Global Inc — how do they compare? Illumina, Inc. trades at $184.68 (market cap $27.94B), while Payoneer Global Inc trades at $7.13 (market cap $2.41B). The key difference: Illumina, Inc. is far larger — about 11.6× Payoneer Global Inc's market cap. Which is the better fit depends on your goals.
| ILMN | PAYO | |
|---|---|---|
Market Cap | $27.94B | $2.41B |
Sector | Health | Technology |
52-Week High | $194.33 | $7.42 |
52-Week Low | $91.00 | $4.27 |
Enterprise Value | $29.33B | $2.15B |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →